
    
      Protocol No: TLC599A2003 Name of Finished Product: TLC599

      Title of Study:

      A Phase IIa, Randomized, Double blinded, Placebo controlled, Dose finding Study for Single
      dose Administration of TLC599 in Patients with Osteoarthritis (OA) of Knee.

      Study duration:

      The trial will last around 27 weeks including a 21-day screening period and a 24-week
      follow-up period.
    
  